Ep 13: Psychedelic Science: Understanding the Emerging Research and Potential Therapeutic Applications
On this month’s episode, we are joined by James Schwartz, BSN, LNC CEO of Cascade High Organics. James published an article about psilocybin and PTSD with Cannabis Science and Technology that was one of the most popular pieces of content on our website for the year. Together, we discuss James’ cannabis background, knowledge about psychedelics, and his recent focus on the dangers of the 2018 Farm Bill in the hemp market.
The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!